These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32586174)

  • 101. Equivalent live-birth rate in antagonist IVF/ICSI protocol after oocyte triggering with GnRH agonist supplemented with 1500 r-hCG the day of oocyte retrieval vs r-hCG : A case-control study.
    Cherrière F; Arvis P; Le Pabic E; Bidet M; Jaffré F; Guivarc'h-Levêque A
    J Gynecol Obstet Hum Reprod; 2020 Jun; 49(6):101702. PubMed ID: 32018042
    [TBL] [Abstract][Full Text] [Related]  

  • 102. [Impact of controlled ovarian hyperstimulation delayed, which occurs after functionally pituitary downregulation by depot GnRH agonist, on the outcome of in vitro fertilization and embryo transfer].
    Ma QH; Li SW; Huang ZY; Han ZY; Qiu DS; Han DW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):980-3. PubMed ID: 18095601
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Gonadotropin-releasing hormone and reproductive medicine.
    Shalev E; Leung PC
    J Obstet Gynaecol Can; 2003 Feb; 25(2):98-113. PubMed ID: 12577127
    [TBL] [Abstract][Full Text] [Related]  

  • 104. The relationship between dominant follicle development and clinical outcomes of hormone replacement therapy-frozen embryo transfer: a retrospective clinical study.
    Huang C; Shen X; Yan Y; Shan H; Shi Q; Mei J; Xing J
    Front Endocrinol (Lausanne); 2023; 14():1192696. PubMed ID: 37388209
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Disparities in reproductive outcomes according to the endometrial preparation protocol in frozen embryo transfer : The risk of early pregnancy loss in frozen embryo transfer cycles.
    Hatoum I; Bellon L; Swierkowski N; Ouazana M; Bouba S; Fathallah K; Paillusson B; Bailly M; Boitrelle F; Alter L; Bergère M; Selva J; Wainer R
    J Assist Reprod Genet; 2018 Mar; 35(3):425-429. PubMed ID: 29110260
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Clinical Outcomes in Hormone Replacement Therapy (HRT)-Frozen Embryo Transfer (FET) Protocol Increased by Administering Gonadotropin-Releasing Hormone Agonist (GnRH) in the Initial Stage of the Luteal Phase: A Retrospective Analysis.
    Mahmood A; Tan L
    Cureus; 2024 Feb; 16(2):e53877. PubMed ID: 38465078
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Flexible GnRH Antagonist Protocol versus Progestin-primed Ovarian Stimulation (PPOS) Protocol in Patients with Polycystic Ovary Syndrome: Comparison of Clinical Outcomes and Ovarian Response.
    Xiao ZN; Peng JL; Yang J; Xu WM
    Curr Med Sci; 2019 Jun; 39(3):431-436. PubMed ID: 31209815
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles.
    Huong DL; Wechsler B; Vauthier-Brouzes D; Duhaut P; Costedoat N; Lefebvre G; Piette JC
    Semin Arthritis Rheum; 2002 Dec; 32(3):174-88. PubMed ID: 12528082
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.
    Wu Z; Li R; Ma Y; Deng B; Zhang X; Meng Y; Chen X; Liu P; Qiao J
    Reprod Biomed Online; 2012 May; 24(5):511-20. PubMed ID: 22417667
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Gonadotropin-releasing hormone agonist (GnRHa) trigger - State of the art.
    Dosouto C; Haahr T; Humaidan P
    Reprod Biol; 2017 Mar; 17(1):1-8. PubMed ID: 28215488
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Prolonging GnRH-agonist to achieve ovarian suppression does not compromise the results of a long protocol.
    Dessolle L; Ferrier D; Colombel A; Fréour T; Jean M; Barrière P
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):111-4. PubMed ID: 21763059
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [TBL] [Abstract][Full Text] [Related]  

  • 113. The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).
    Segars JH; Hill GA; Bryan SH; Herbert CM; Osteen KG; Rogers BJ; Wentz AC
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):327-31. PubMed ID: 2127603
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Live birth rate in fresh and frozen embryo transfer cycles in women with endometriosis.
    Mohamed AM; Chouliaras S; Jones CJ; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2011 Jun; 156(2):177-80. PubMed ID: 21353737
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
    Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The effect of endometrial thickness on pregnancy outcomes of frozen-thawed embryo transfer cycles which underwent hormone replacement therapy.
    Shaodi Z; Qiuyuan L; Yisha Y; Cuilian Z
    PLoS One; 2020; 15(9):e0239120. PubMed ID: 32970718
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The influence of seasonal variations on in vitro fertilization and fresh/frozen embryo transfer: a retrospective study.
    Xiao Y; Wang M; Liu K
    Arch Gynecol Obstet; 2018 Sep; 298(3):649-654. PubMed ID: 29971557
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
    Wu L; Ren XL; Chen W; Huang B; Zhou YF; Jin L
    Curr Med Sci; 2019 Jun; 39(3):437-441. PubMed ID: 31209816
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome - a prospective randomized double-blind clinical trial.
    Engmann LL; Maslow BS; Kaye LA; Griffin DW; DiLuigi AJ; Schmidt DW; Grow DR; Nulsen JC; Benadiva CA
    J Ovarian Res; 2019 Jan; 12(1):8. PubMed ID: 30684970
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Comparison of outcomes and direct cost between minimal stimulation and conventional protocols on ovarian stimulation in in vitro fertilization.
    Sophonsritsuk A; Choktanasiri W; Weerakiet S; Rojanasakul A
    J Obstet Gynaecol Res; 2005 Oct; 31(5):459-63. PubMed ID: 16176518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.